|
| 34980229 | Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis. | J Exp Clin Cancer Res | 2022 |
| 36497479 | Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma. | Cancers (Basel) | 2022 |
| 33908607 | MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress. | Blood | 2022 |
| 34980229 | Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis. | J Exp Clin Cancer Res | 2022 |
| 36497479 | Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma. | Cancers (Basel) | 2022 |
| 33908607 | MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress. | Blood | 2022 |
| 34654445 | Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis. | J Exp Clin Cancer Res | 2021 |
| 34440851 | Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function. | Cells | 2021 |
| 34654445 | Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis. | J Exp Clin Cancer Res | 2021 |
| 34440851 | Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function. | Cells | 2021 |
| 32610710 | MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo. | Cells | 2020 |
| 32610710 | MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo. | Cells | 2020 |
| 31406155 | Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation. | Cell Death Dis | 2019 |
| 31406155 | Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation. | Cell Death Dis | 2019 |
| 29489754 | The landscape of genomic alterations across childhood cancers. | Nature | 2018 |
| 30193837 | Matrix mineralization controls gene expression in osteoblastic cells. | Exp Cell Res | 2018 |
| 30038364 | Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation. | Cell Death Dis | 2018 |
| 29489754 | The landscape of genomic alterations across childhood cancers. | Nature | 2018 |
| 29755686 | Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy. | Oncotarget | 2018 |
| 30193837 | Matrix mineralization controls gene expression in osteoblastic cells. | Exp Cell Res | 2018 |
| 30038364 | Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation. | Cell Death Dis | 2018 |
| 29755686 | Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy. | Oncotarget | 2018 |
| 28638739 | Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells. | Oncoimmunology | 2017 |
| 28344885 | Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma <i>in vitro</i> and <i>in vivo</i>. | Oncoimmunology | 2017 |
| 28638739 | Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells. | Oncoimmunology | 2017 |
| 28319320 | The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma. | Mol Oncol | 2017 |
| 28344885 | Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma <i>in vitro</i> and <i>in vivo</i>. | Oncoimmunology | 2017 |
| 28319320 | The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma. | Mol Oncol | 2017 |
| 26752546 | Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas. | Am J Surg Pathol | 2016 |
| 26752546 | Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas. | Am J Surg Pathol | 2016 |
| 26802024 | The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease. | Oncotarget | 2016 |
| 27363011 | The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma. | Oncotarget | 2016 |
| 27315524 | The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. | Clin Sarcoma Res | 2016 |
| 27471654 | Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity. | Oncoimmunology | 2016 |
| 27447745 | Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens. | Oncotarget | 2016 |
| 26623725 | Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma. | Oncotarget | 2016 |
| 27735950 | Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation. | Cell Death Dis | 2016 |
| 26623725 | Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma. | Oncotarget | 2016 |
| 27735950 | Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation. | Cell Death Dis | 2016 |
| 27363011 | The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma. | Oncotarget | 2016 |
| 27447745 | Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens. | Oncotarget | 2016 |
| 27471654 | Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity. | Oncoimmunology | 2016 |
| 27315524 | The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. | Clin Sarcoma Res | 2016 |
| 26802024 | The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease. | Oncotarget | 2016 |
| 25888699 | Nomenclature of Toso, Fas apoptosis inhibitory molecule 3, and IgM FcR. | J Immunol | 2015 |
| 25888699 | Nomenclature of Toso, Fas apoptosis inhibitory molecule 3, and IgM FcR. | J Immunol | 2015 |
| 26179511 | Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma. | Clin Cancer Res | 2015 |
| 26052074 | T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice. | Gastroenterology | 2015 |
| 26052074 | T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice. | Gastroenterology | 2015 |
| 26179511 | Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma. | Clin Cancer Res | 2015 |